CA2671067A1 - Acides gymnemiques destines a des applications antifongiques - Google Patents

Acides gymnemiques destines a des applications antifongiques Download PDF

Info

Publication number
CA2671067A1
CA2671067A1 CA2671067A CA2671067A CA2671067A1 CA 2671067 A1 CA2671067 A1 CA 2671067A1 CA 2671067 A CA2671067 A CA 2671067A CA 2671067 A CA2671067 A CA 2671067A CA 2671067 A1 CA2671067 A1 CA 2671067A1
Authority
CA
Canada
Prior art keywords
gymnemic
acids
pharmaceutically acceptable
fungus
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2671067A
Other languages
English (en)
Inventor
Govindsamy Vediyappan
Christophe D'enfert
Vincent Dumontet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut Pasteur de Lille
Original Assignee
Centre National de la Recherche Scientifique CNRS
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Institut Pasteur de Lille filed Critical Centre National de la Recherche Scientifique CNRS
Priority to CA2671067A priority Critical patent/CA2671067A1/fr
Priority to CA2708919A priority patent/CA2708919A1/fr
Priority to PCT/EP2010/059473 priority patent/WO2011000946A1/fr
Publication of CA2671067A1 publication Critical patent/CA2671067A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2671067A 2009-07-02 2009-07-02 Acides gymnemiques destines a des applications antifongiques Abandoned CA2671067A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA2671067A CA2671067A1 (fr) 2009-07-02 2009-07-02 Acides gymnemiques destines a des applications antifongiques
CA2708919A CA2708919A1 (fr) 2009-07-02 2010-06-30 Acides gymnemiques destines a des applications antifongiques
PCT/EP2010/059473 WO2011000946A1 (fr) 2009-07-02 2010-07-02 Acides gymnémiques pour applications antifongiques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2671067A CA2671067A1 (fr) 2009-07-02 2009-07-02 Acides gymnemiques destines a des applications antifongiques

Publications (1)

Publication Number Publication Date
CA2671067A1 true CA2671067A1 (fr) 2011-01-02

Family

ID=42830327

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2671067A Abandoned CA2671067A1 (fr) 2009-07-02 2009-07-02 Acides gymnemiques destines a des applications antifongiques
CA2708919A Abandoned CA2708919A1 (fr) 2009-07-02 2010-06-30 Acides gymnemiques destines a des applications antifongiques

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA2708919A Abandoned CA2708919A1 (fr) 2009-07-02 2010-06-30 Acides gymnemiques destines a des applications antifongiques

Country Status (2)

Country Link
CA (2) CA2671067A1 (fr)
WO (1) WO2011000946A1 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080241281A1 (en) 2007-03-29 2008-10-02 Texas Tech University System Compositions & methods for activation and inhibition of Staphylococcus aureus biofilm development

Also Published As

Publication number Publication date
CA2708919A1 (fr) 2011-01-02
WO2011000946A1 (fr) 2011-01-06

Similar Documents

Publication Publication Date Title
Li et al. Intranasal pretreatment with Z-Ligustilide, the main volatile component of Rhizoma Chuanxiong, confers prophylaxis against cerebral ischemia via Nrf2 and HSP70 signaling pathways
CN110325187A (zh) 治疗流感的方法
Yang et al. Cinnamaldehyde attenuates pressure overload-induced cardiac hypertrophy
KR102487075B1 (ko) 비알코올성 지방성 간 질환의 예방 및 치료약
TW201043226A (en) Salts of 3-pentylphenylacetic acid and pharmaceutical uses thereof
Liu et al. The parthenolide derivative ACT001 synergizes with low doses of L-DOPA to improve MPTP-induced Parkinson’s disease in mice
Zhang et al. Glutamine ameliorates lipopolysaccharide‑induced cardiac dysfunction by regulating the toll‑like receptor 4/mitogen‑activated protein kinase/nuclear factor‑κB signaling pathway
JPWO2009096455A1 (ja) 脂肪性肝疾患の治療用医薬組成物
US9475836B2 (en) Protopanoxadiol derivative, preparation method thereof and application thereof
TW202322837A (zh) 調節腸道通透性及/或治療及/或預防腸漏相關疾病之組成物以及中草藥複方藥材或中草藥複方萃取物的用途
JP5145563B2 (ja) 神経変性疾患治療薬
US8969410B1 (en) Pharmaceutical composition for alleviating or treating gout and uses thereof
CA2671067A1 (fr) Acides gymnemiques destines a des applications antifongiques
US20220031660A1 (en) Cancer treatment composition
KR101144715B1 (ko) 정자수 증가용 경구 투여제
CN101181287A (zh) 葛根素在制备尿酸转运子urat1抑制药物中的应用
EP3139911B1 (fr) Procédé de traitement d'une stéatohépatite non alcoolique avancée
CN110384692B (zh) 鼠尾草酸和迷迭香酸联合制备防治ⅱ型糖尿病肾病的药物的用途
US11826396B2 (en) Nutriprotective diet
WO2019242764A1 (fr) Application de glycosides dans la préparation de médicaments pour la prévention et le traitement de complications du diabète
CN111228259A (zh) 5-羟基-1-甲基海因的医药用途
KR101342851B1 (ko) 신규한 피토스핑고신 유도체 및 이를 포함하는 염증성 피부질환, 자가면역질환 및 피부과다각화증질환 예방 및 치료용 조성물
CN102861001B (zh) 桂皮醛治疗胃炎新用途
Rezaiezadeh et al. Therapeutic potential of Bergenin in the management of neurological-based diseases and disorders
WO2015015248A1 (fr) Utilisation de composés présentant des propriétés co-induisant la protéine de choc thermique (hsp) pour améliorer l'effet de sensibilisation à l'insuline dans le traitement du diabète de type 2

Legal Events

Date Code Title Description
FZDE Dead